Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ARID3A encodes a member of the ARID (AT-rich interaction domain) family of DNA binding proteins. Additionally we are shipping ARID3A Proteins (5) and many more products for this protein.
Showing 10 out of 81 products:
Human Monoclonal ARID3A Primary Antibody for IF, WB - ABIN393983
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for ABIN393983
Cow (Bovine) Polyclonal ARID3A Primary Antibody for WB - ABIN2780661
Lin, Ippolito, Zong, Bryant, Koslovsky, Tucker: Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. in Molecular cancer 2007
Human Polyclonal ARID3A Primary Antibody for ICC, IF - ABIN151747
Fukuyo, Horikoshi, Ishov, Silverstein, Nakajima: The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. in Journal of virology 2011
Human Monoclonal ARID3A Primary Antibody for IF, IHC (p) - ABIN560650
Kang, Yeom, Kim, Kim, Lee: Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry. in Journal of proteomics 2012
Cow (Bovine) Polyclonal ARID3A Primary Antibody for WB - ABIN2777639
Fukuyo, Mogi, Tsunematsu, Nakajima: E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies. in Cell death and differentiation 2004
results suggest that appropriate regulation of ARID3a is critical for normal development of both myeloid and B lineage pathways.
These data reveal new functions for ARID3a in early hematopoiesis and suggest that knowledge regarding ARID3a levels in HSPCs could be informative for applications requiring transplantation of those cells.
Systemic lupus erythematosus (SLE) patients had increased ARID3a+ B cells compared to healthy controls. ARID3a was not expressed in naive B cells of controls, but was abundant in SLE patients. Number of ARID3a+ B cells correlated with disease activity.
miR (show MLXIP Antibodies)-125b can act as an oncogene (show RAB1A Antibodies) in B-cell acute lymphoblastic leukemia by targeting ARID3a and mediating its repression.
These findings support the hypothesis that Epstein-Barr virus EBNA1 (show EBNA-1 Antibodies) initiates transcription at the C promoter via interactions between multiple EBNA1 (show EBNA-1 Antibodies) homodimers and cellular transcription such as E2F1 (show E2F1 Antibodies), ARID3A and Oct-2.
These results indicate both cooperative and interdependent roles for ARID3A and p53 (show TP53 Antibodies) in the transcriptional activation of p21(WAF1 (show CDKN1A Antibodies)) in response to DNA damage.
functions as a critical antagonist to the p16(INK4A (show CDKN2A Antibodies))-Rb tumor suppressor machinery by regulating promyelocytic leukemia protein (show PML Antibodies) stability
report that E2FBP1 inhibits accumulation of ICP0 RNA and, at the same time, is degraded via ICP0's herpes ubiquitin ligase 2 (HUL-2) activity upon HSV-1 infection.
Bright/ARID3a inhibition causes increased developmental plasticity in mouse and human cells.
Solution NMR structure of the ARID domain of human ARID3A.
dril1 is a novel regulator of TGF(beta (show TGFB1 Antibodies)) signaling and a vital component of mesodermal patterning and embryonic morphogenesis.
identify the Arid3a transcription factor as a key target of Let-7, whose ectopic expression is sufficient to induce B-1 development in adult pro-B cells and whose silencing by knockdown blocks B-1 development in fetal pro-B cells.
identify Arid3a as a critical regulator of TE and placental development through execution of the commitment and differentiation phases of the first cell fate decision
these results place Bright/Arid3a on a select list of transcriptional regulators required to program both hematopoietic stem cell and lineage-specific differentiation.
Id1 (show ID1 Antibodies) inhibited DNA binding by Dril1, and the two proteins co-localized in vitro and in vivo, providing a potential mechanism for suppression of fibrosis by Id1 (show ID1 Antibodies) through inhibition of the profibrotic function of Dril1.(Dril1)
The ability of Bright to enhance immunoglobulin transcription critically requires functional Bruton's tyrosine kinase (show BTK Antibodies) .
For IgH transactivation, Bright binds to nuclear matrix association regions.Bright actively shuttles between the nucleus and the cytoplasm, regulation of Bright's cellular localization appears to be required for its function.
Bright functions in a subset of Bruton's tyrosine kinase (show BTK Antibodies)-dependent pathways in vivo, particularly those responses dominated by B1 B cells.
This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA binding proteins. It was found by homology to the Drosophila dead ringer gene, which is important for normal embryogenesis. Other ARID family members have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation, and possibly in chromatin structure modification.
AT rich interactive domain 3A (BRIGHT-like)
, AT-rich interactive domain-containing protein 3A-like
, AT-rich interactive domain-containing protein 3A
, dead ringer homolog 1
, ARID domain-containing 3A
, ARID domain-containing protein 3A
, AT rich interactive domain 3A (BRIGHT- like) protein
, B-cell regulator of IgH transcription
, E2F-binding protein 1
, dead ringer-like 1
, dead ringer-like protein 1
, bright homolog
, AT rich interactive domain 3A (Bright like)